HALO logo
halo search icon
SPL
Starpharma Holdings Limited

SPL · Starpharma Holdings Limited

0.72

AUD
-0.005 (-0.685%)
26/08/2026 04:10:14 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$348.25M

PE

N/A

EV/EBITDA

N/A

DIV Yield

N/A

Franking

N/A

MQV Rating

5Very Weak

As at 26/08/2026 04:10:14 PM

Price Chart

Description

Starpharma Holdings Ltd. engages in the research, development, and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its pipeline and products include SN38, cabazitaxel, docetaxel, radiopharmaceuticals, antibody-drug conjugates, and anti-infective products. The company was founded in 1996 and is headquartered in Abbotsford, Australia.

  • All-Companies
  • All-Consensus
  • Consensus Cheap
  • GROWTH AUS
  • HALO Ords
  • Hammer Bearish
  • Hammer Bearish (Realtime)

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

N/A

Trade Value (12mth)

N/A

1 week

%

1 month

%

YTD

%

1 year

%

All time high

N/A

Additional Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

N/A

Short Sell (% of issue)

lock

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Neutral

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
26 August 26ASXD
26 August 26ASXD
26 August 26ASXD
26 August 26ASXD
24 August 26ASXD

Key Stakeholders

NameTitle
Rhuroin Pty Ltd.Private Company
Peter Gerard CookIndividual
UIL Ltd.Mutual Fd-Closed End
Robmar Investments Pty Ltd.Private Company
Ingot Capital Investments Pty Ltd.Private Company

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Starpharma Holdings Limited (SPL:ASX)?
Halo FAQ
The current share price of Starpharma Holdings Limited (SPL:ASX) is AUD$0.72.
2
What is the 52-week high share price for Starpharma Holdings Limited (SPL:ASX)?
Halo FAQ
The 52-week high share price for Starpharma Holdings Limited (SPL:ASX) is AUD$0.00.
3
What is the 52-week low share price for Starpharma Holdings Limited (SPL:ASX)?
Halo FAQ
The 52-week low share price for Starpharma Holdings Limited (SPL:ASX) is AUD$0.00.
4
What is the dividend yield for Starpharma Holdings Limited (SPL:ASX)?
Halo FAQ
Starpharma Holdings Limited (SPL:ASX) does not pay a dividend.
5
What was Starpharma Holdings Limited (SPL:ASX) last dividend payment?
Halo FAQ
Starpharma Holdings Limited (SPL:ASX) does not pay a dividend.
6
What is the franking level for Starpharma Holdings Limited (SPL:ASX)?
Halo FAQ
Starpharma Holdings Limited (SPL:ASX) has a franking level of 0.00%.
7
In which sector is Starpharma Holdings Limited (SPL:ASX) classified?
Halo FAQ
Starpharma Holdings Limited (SPL:ASX) is classified in the Healthcare.